To further investigate how CPPs treatment attenuated cognitive deficits and whether it affected synaptic plasticity in APP/PS1 mice, the expression of PSD95 and synaptotagmin was evaluated in the hippocampal homogenate by western blot in all groups. The gene discussed is APP; the disease is Cognitive impairment.